Former Pfizer CEO joins investment firm
Ian Read, who stepped down as Pfizer CEO last January, is joining The Carlyle Group as operating executive for global healthcare. He will help the healthcare team identify investment opportunities and advise portfolio companies on growth strategies.
Zimmer Biomet names comms chief
Keri Mattox has joined Zimmer Biomet as SVP of investor relations and chief communications officer. Previously, Mattox was global lead of integrated corporate communications at W2O.
Ironshore Pharmaceuticals appoints two executives
Ironshore has hired Dave Lemus as its chief financial officer and promoted Peter Lammers to chief commercial officer.
Prime Therapeutics names CFO
David Schlett has joined Prime Therapeutics as chief financial officer. Schlett previously worked at Cambridge Advisory Group and held leadership roles at Medco and Express Scripts.
Arrowhead Pharmaceuticals appoints commercial head
James Hassard has been named chief commercial officer at Arrowhead. Hassard joined the company from Coherus BioSciences, where he served as SVP of marketing and market access.
TGaS Advisors announces promotions
The advisory firm named one new hire and made several promotions. Ken McDermott joined the company as VP, executive commercial operations. Karl Kraft was promoted to SVP, commercial solutions; Steve Regan was named VP, learning and development; and Chris Weleski was appointed VP, marketing operations and medical/regulatory/legal solutions.
The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Carrie Gavit at firstname.lastname@example.org.